Testing effectiveness (Phase 2)Ended earlyNCT00060710What this trial is testingCP-461 in the Treatment of Patients With Advanced MelanomaWho this might be right forMalignant Melanoma Astellas Pharma Inc 35
Not applicableEnded earlyNCT01836640What this trial is testingDeveloping Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Dartmouth-Hitchcock Medical Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT06117540What this trial is testingWX390 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Shanghai Jiatan Pharmatech Co., Ltd 70
Not applicableStudy completedNCT04431830What this trial is testingMeaning-Centered Pain Coping Skills TrainingWho this might be right forAdvanced Solid TumorPain Duke University 60
Early research (Phase 1)Study completedNCT05508100What this trial is testingDose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid TumorsWho this might be right forAdvanced Solid Tumor Immune-Onc Therapeutics 38
Early research (Phase 1)Study completedNCT04060511What this trial is testingHS-10342 in Patients With Advanced Solid TumorWho this might be right forAdvanced Solid Tumor Jiangsu Hansoh Pharmaceutical Co., Ltd. 17
Not applicableEnded earlyNCT05471271What this trial is testingIL-2 PET Imaging in Advanced Solid TumoursWho this might be right forMetastatic Solid Tumor University Medical Center Groningen 1
Testing effectiveness (Phase 2)UnknownNCT04376931What this trial is testingA Prospective Dose Finding Study of Iscador InfusionWho this might be right forAdvanced Cancer HaEmek Medical Center, Israel 24
Testing effectiveness (Phase 2)Study completedNCT00006357What this trial is testingSTI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaWho this might be right forEndometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 91
Early research (Phase 1)UnknownNCT03645200What this trial is testingTreatment of Carrying TP53 Harmful MutationsWho this might be right forAdvanced Cancer Tianjin Medical University Second Hospital 60
Early research (Phase 1)Study completedNCT02834611What this trial is testingCeramide NanoLiposome in Patients With Advanced Solid TumorsWho this might be right forCancerCarcinomaSolid Tumors+1 more Keystone Nano, Inc 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053What this trial is testingRare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Who this might be right forRare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Early research (Phase 1)Looking for participantsNCT06493864What this trial is testingBL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 21
Early research (Phase 1)UnknownNCT05461287What this trial is testingSafety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Qilu Pharmaceutical Co., Ltd. 290
Large-scale testing (Phase 3)Looking for participantsNCT07678229What this trial is testingBRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCLWho this might be right forExtranodal NK/T-cell Lymphoma Rong Tao 150
Early research (Phase 1)Study completedNCT04739111What this trial is testingAn Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant TumorWho this might be right forAdvanced Malignant Tumor Dragonboat Biopharmaceutical Company Limited 12
Early research (Phase 1)Ended earlyNCT04167137What this trial is testingSafety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult ParticipantsWho this might be right forMetastatic Solid NeoplasmLymphoma Synlogic 32
Early research (Phase 1)Study completedNCT01225536What this trial is testingDose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS MutationsWho this might be right forSolid Tumor ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 24
Early research (Phase 1)Study completedNCT04811898What this trial is testingA Dose Escalation Study of LNA-i-Mir-221 for Cancer TreatmentWho this might be right forMultiple Myeloma, RefractoryHepatocarcinomaAdvanced Solid Tumor Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 17